Keywords: lundbeck, enter, phase, iii, new, celexa, formulation

Lundbeck to enter Phase III with new Celexa formulation

Article | 06 July 2000

Biovail says that it has completed development of acontrolled-release formulation of the antidepressant Celexa (citalopram), originally developed by Lundbeck. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lundbeck

Go to company listing

Related Drugs

Celexa

citalopram

Go to drug listing